Skip to main content
Log in

Effects of small doses of bisoprolol on blood pressure and lipoprotein concentrations in hypertensive patients

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The effects of bisoprolol 2.5 and 5 mg per day on blood pressure, and lipoprotein and apolipoprotein concentrations were compared in 18 newly detected hypertensives in a double-blind, crossover study. All treatment results were related to the values at the end of a four-week placebo run-in period. Each of the two following treatment periods lasted for 3 months.

The systolic and diastolic pressures in the supine position were reduced by 19.5/11.7 mm Hg and 14.6/10.4 mm Hg by 2.5 and 5 mg bisoprolol per day, respectively, with no significant difference in effect. Supine heart rate was reduced by 4.7 and 8.2 beats · min−1, respectively, (P=0.0517 for different effects).

The cholesterol concentration in low-density (LDL) and high-density (HDL) lipoproteins was reduced during both regimens, by about 0.3 and 0.1 mmol·l−1, respectively, difference not significant. Triglyceride concentrations were not significantly affected during either regimen.

We conclude that, in this study population, treatment with bisoprolol 2.5 mg per day was equally effective as 5.0 mg per day in reducing blood pressure. The effects on lipoprotein concentrations were small and included an unexpected reduction in LDL-cholesterol concentration. A low dose of a highly selective β-adrenoceptor blocker like bisoprolol appears to retain the blood pressure reducing capacity and has lost most of the unfavourable effects on lipoproteins characteristic of higher doses.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Häusler G, Schliep H-J, Schelling P, Becker KH, Klockow M, Minck KO, Enenkel HJ, Schulze E, Bergmann R, Schmitges C-J, Seyfried C, Harting J (1986) High β1-selectivity and favourable pharmacokinetics as the outstanding properties of bisoprolol. J Cardiovasc Pharmacol 8 [Suppl 11]: S2-S15

    Google Scholar 

  2. Leopold G (1986) Balanced pharmacokinetics and metabolism of bisoprolol. J Cardiovasc Pharmacol 8 [Suppl 11]: S16-S20

    Google Scholar 

  3. Lithell H, Weiner L, Selinus I, Vessby B (1986) A comparison of the effects of bisoprolol and atenolol on lipoprotein concentrations and blood pressure. J Cardiovasc Pharmacol 8 [Suppl 11]: S128-S133

    Google Scholar 

  4. Frithz G, Weiner L (1986) Long-term effects of bisoprolol on blood pressure, serum lipids, and HDL-cholesterol in patients with essential hypertension. J Cardiovasc Pharmacol 8 [Suppl 1]: S134-S138

    Google Scholar 

  5. Ames RP (1986) The effects of antihypertensive drugs on serum lipids and lipoproteins. II. Non diuretic drugs. Drugs 32: 335–357

    Google Scholar 

  6. Castelli WP (1986) The triglyceride issue: a view from Framingham. Am Heart J 112: 432–437

    Google Scholar 

  7. Bühring KU, Garbe A (1986) Determination of the new β-blocker bisoprolol and of metoprolol, antenolol and propranolol in plasma and urine by high-performance liquid chromatography. J Chromatogr 382: 215–224

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lithell, H., Weiner, L., Vessby, B. et al. Effects of small doses of bisoprolol on blood pressure and lipoprotein concentrations in hypertensive patients. Eur J Clin Pharmacol 44, 19–22 (1993). https://doi.org/10.1007/BF00315274

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00315274

Key words

Navigation